SCULLY WILLIAM P purchased $890K of PRTA (indirect holdings)
SCULLY WILLIAM P purchased 103,500 indirectly-held shares of PROTHENA CORP PUBLIC LTD CO (PRTA) at $8.60 ($0.89M total) on 2026-09-28.
How this was made
The 30-second read
Why it matters
The purchase may signal confidence in upcoming milestones, prompting short sellers to cover.
Market read
Insider buying in a small‑cap biotech can move the stock and attract trader attention.
What to watch
Potential upcoming financing rounds or clinical trial outcomes not disclosed.
Background
SEC Form 4 filing provides the first public disclosure of the insider transaction.
Ticker impact
Form 4 shows insider William Scully purchased 103,500 shares for $889,872, increasing his stake to 187,000 shares (10% owner).
likely upward pressure as market prices in insider confidence
The purchase is sizable relative to float and comes from a 10% owner, indicating material support for the stock.
Market effects
Minimal; reflects confidence in Prothena's biotech pipeline.
None
Low
Counterpoint
Insider buying could be a defensive move ahead of upcoming dilution or negative news.
Key entities
- CompanyProthena Corp Public Ltd Co
Biotech firm listed on NASDAQ (PRTA).
- InsiderWilliam Scully
10% owner executing an open‑market purchase.